The incidence of endometrial cancer is on the rise, along with a concurrent increase in mortality. For advanced-stage endometrial cancer, standard treatment regimens include surgery, radiation, and cytotoxic chemotherapy; however, options are limited in the recurrent disease setting. Antibody–drug conjugates (ADCs) hav...
Yusuke Matoba, Esther P. B. Rodman, M. Mohammadabadi et al.· Uterine Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.